HOM 2018-save the date (R10) · disease, atrial ˚brillation, and diabetes. Prof Dr Michael Böhm...
Transcript of HOM 2018-save the date (R10) · disease, atrial ˚brillation, and diabetes. Prof Dr Michael Böhm...
8 – 9 September 2018 | Hilton Hotel Kuala Lumpur
• Controversial topics and stimulating science
S A V E T H E D A T E
• Leading international experts
• Clinical trial updates and pipeline
• Live interaction of audience using digital tools
SYMPOSIUM ON THE CONCEPTS &CONTROVERSIES IN HEART FAILURE
For Healthcare Professionals Only
ACCREDITATIONw
ill be accredited
CME Points
H of the
Novartis Corporation (Malaysia) Sdn Bhd (10920H)
Level 22, Tower B, Plaza 33, No. 1, Jalan Kemajuan, Seksyen 13, 46200 Petaling Jaya, Selangor Darul EhsanTel : +603 7948 1888 Fax: +603 7948 1818 Website: www.novartis.com HO
M.IN
V.0
1/M
Y18
0583
4114
For RSVP: Kindly contact, Mr Reinus HiewMobile: +6017 260 3977, Email: [email protected]
AGENDA: DAY 2 9 September 2018
SYMPOSIUM ON THE CONCEPTS &CONTROVERSIES IN HEART FAILURE
8 – 9 September 2018 | Hilton Hotel Kuala Lumpur
For Healthcare Professionals Only
H of the
0715 – 0800
0800 – 0915
0915 – 0940
0940 – 1005
1005 – 1030
1030 – 1055
1055 – 1115
1115 – 1140
1140 – 1205
1205 – 1230
1230 – 1255
1255 – 1320
1320 – 1335
1335 – 1340
Breakfast and Registration
Session I: Optimizing Heart Failure Services
HF Clinic Workshop: A Multidisciplinary Approach
Session II: CHF and AHF – Navigating the Challenges
How to Improve Time to First Diagnosis in AHF?
Complexities of Heart Failure – What the Heart Failure Guidelines Did and Didn’t Tell Us
Ischemic Cardiomyopathy – Revascularization or HF Therapy First?
Panel Q&A Session
Coffee/ Tea Break
Managing Diabetes and Renal Impairment in Heart Failure
HF with Preserved Ejection Fraction – Is there a Key Mechanism?
A Rude Awakening: Sleep Apnoea and HF (CPAP Controversy)
Biomarkers in Heart Failure – Who’s Hot and Who’s Not
Much Ado about Heart Failure Prognostic Models: To Score or Not to Score?
Panel Q&A Session
Summary and Closing Remarks
Lunch Break & Networking
TIME SESSION
AGENDA: DAY 1 8 September 2018
0830 – 0920
0920 – 0930
0930 – 0950
0950 – 1020
1020 – 1040
1040 – 1110
1110 – 1140
1140 – 1155
1155 – 1220
1220 – 1245
1245 – 1310
1310 – 1335
1335 – 1350
1350 – 1450
1450 – 1515
1515 – 1540
1540 – 1605
1605 – 1630
1630 – 1645
1645 – 1700
1700 – 1715
1715 – 1730
1730 – 1745
1745 – 1815
1815 – 1830
1830 – 1845
1845 – 2000
Breakfast and Registration
Welcome and Introduction
Session IA: Treatment of Chronic Heart Failure (Part 1)
De�nition & Algorithm for a Diagnosis of Chronic Heart Failure
PARADIGM-HF Trial – Taking a Closer Look at Special Populations
Coffee/ Tea Break
What have we Learned since the Publication of PARADIGM-HF
The Conundrum of the Stable Heart Failure Patient
Panel Q&A Session
Session IB: Treatment of Chronic Heart Failure (Part 2)
Cardiac Resynchronization Therapy: A Review of Evidence
Sudden Cardiac Death in CCF Patients
Mitral and Tricuspid Regurgitation in HF – A Surgical Perspective
Mechanical Circulatory Support: LVADs & Heart Transplantation: Now and in the Future
Panel Q&A session
Lunch
Session II: Challenging Cases In Chronic Heart Failure
Co-morbidities in Chronic Heart Failure
‘Stable’ Heart Failure Patient – Can You Believe What You See?
Advanced Heart Failure
HF with AF: Vicious Twins
Panel Q&A Session
Session III: Heart Failure And Its Economics In Asia
Heart Failure in Asia – Prevalence, Disease Severity & Economic Impact
Focus on Clinical Trials: The Changing and Challenging Trend of Asian Involvement
Panel Q&A Session
Coffee/ Tea Break
Session IV: Advances and Future Prospects
Treatment of Chronic Heart Failure: Clinical Trial Update and Pipeline
LDL Cholesterol & In�ammation: Controversies and Future Therapeutic Directions
Panel Q&A Session
Dinner
TIME SESSION Prof Dr John JV McMurray
Dr John JV McMurray is a Professor of Medical Cardiology and Deputy Director of the Institute of Cardiovascular and Medical Sciences at the University of Glasgow, UK. He has also served as a distinguished member of the European Society of Cardiology (ESC) faculty, and has chaired several guideline committees, including the 2012 ESC Heart Failure Guidelines task force. Professor McMurray is a member of the editorial board of the New England Journal of Medicine and several other leading cardiovascular journals, including the European Heart Journal and Circulation. He is recognized as being one of the most in�uential biomedical researchers in the world owing to his many high-pro�le clinical trials in heart failure, coronary heart disease, atrial �brillation, and diabetes.
Prof Dr Michael Böhm
Dr Michael Böhm is a Professor of internal medicine and cardiology and director of internal medicine (cardiology, angiology, and intensive care medicine) at the University of Saarland, Homburg, Saarland, Germany. He has served as president of the German society of cardiology; and his special interests include the pathophysiology and therapy of heart failure. In particular, Prof Böhm has been involved in studies on signal transduction in the failing heart and in vascular biology. Professor Böhm has been the principal investigator in several international multicenter studies and has written more than 350 original papers, book chapters and review articles. He has obtained several awards from scienti�c societies, the most important being the Theodor Frerichs Award of the German Society of Internal Medicine, which he received in 1989 for the discovery of mechanisms in heart failure. Professor Böhm is a reviewer for most recognized scienti�c journals in the cardiovascular �eld and is a chief editor of the Clinical Research in Cardiology journal.
Dr Bernard Kwok
Dr Bernard Kwok is Singapore's �rst quali�ed transplant cardiologist, and he established Singapore's �rst multidisciplinary Heart Failure Programme at the National Heart Centre of Singapore (NHCS). He was the Director of the Programme, and continues to care for patients with advanced heart failure and heart transplant recipients as a Visiting Consultant at the NHCS. Dr Kwok is a Clinical Senior Lecturer in the Yong Loo Lin school of Medicine at the National University of Singapore and has previously served as the Governor of the Singapore Chapter of the American College of Cardiology. He was formerly the President of the Singapore Cardiac Society and is the founding President of the Heart Failure Society (Singapore).
Dr Pardeep S Jhund
Dr Pardeep Jhund is a Clinical Senior Lecturer at the University of Glasgow and Honorary Consultant Cardiologist at the Queen Elizabeth University Hospital. His research interests include the epidemiology and co-morbidities associated with heart failure. He also uses clinical trial data sets to further understand the complex syndrome of heart failure. Dr Jhund has extensive experience in the design and conduct of clinical trials through his involvement in a number of multinational randomised trials as an investigator and as a member of clinical endpoint committees. A widely published author, he has published over 70 papers in high impact factor cardiovascular journals.
Dr David Sim Kheng Leng
Adjunct Assistant Professor David Sim is a Senior Consultant with the Department of Cardiology and Director of the Heart Failure Programme at the National Heart Centre Singapore (NHCS). He is chairman of the NHCS Heart Failure Coordinated Care Pathway Committee and has previously served as a member of the Singapore Heart Failure Guidelines Committee in 2014. Dr David Sim has lectured widely on the topic of Heart Failure at both the national and international levels; drawing on his substantial experience as a principal investigator in several large, multinational industry-sponsored trials as well as academic trials. He has published extensively in the area of Heart Failure and interventional cardiology, and his stable of original papers includes tier-one journals.
INTERNATIONAL FACULTY